Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael C Cox, Tu D Dan & Sandra M Swain. (2006) Emerging drugs to replace current leaders in first-line therapy for breast cancer. Expert Opinion on Emerging Drugs 11:3, pages 489-501.
Read now
Read now
Articles from other publishers (10)
Uttpal Anand, Abhijit Dey, Arvind K. Singh Chandel, Rupa Sanyal, Amarnath Mishra, Devendra Kumar Pandey, Valentina De Falco, Arun Upadhyay, Ramesh Kandimalla, Anupama Chaudhary, Jaspreet Kaur Dhanjal, Saikat Dewanjee, Jayalakshmi Vallamkondu & José M. Pérez de la Lastra. (2023) Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics. Genes & Diseases 10:4, pages 1367-1401.
Crossref
Crossref
Snehal R. Jadhav, Gary Bryant, Jitendra P. Mata, Daniel S. Eldridge, Enzo A. Palombo, Ian H. Harding & Rohan M. Shah. (2021) Structural aspects of a self-emulsifying multifunctional amphiphilic excipient: Part II. The case of Cremophor EL. Journal of Molecular Liquids 344, pages 117881.
Crossref
Crossref
Paul L. Chariou, Oscar A. Ortega-Rivera & Nicole F. Steinmetz. (2020) Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients. ACS Nano 14:3, pages 2678-2701.
Crossref
Crossref
Li-Hsien Chen, Yuan-Ting Sun, Yih-Fung Chen, Mei-Yi Lee, Lian-Yun Chang, Jang-Yang Chang & Meng-Ru Shen. (2015) Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy. Molecular Cancer Therapeutics 14:10, pages 2206-2214.
Crossref
Crossref
V. Zabaleta, P. Calleja, S. Espuelas, L. Corrales, R. Pío, M. Agüeros & J.M. Irache. (2013) Nanoparticules mucopénétrantes : véhicules pour l’administration orale du paclitaxel. Annales Pharmaceutiques Françaises 71:2, pages 109-118.
Crossref
Crossref
Virginia Zabaleta, Gilles Ponchel, Hesham Salman, Maite Agüeros, Christine Vauthier & Juan M. Irache. (2012) Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study. European Journal of Pharmaceutics and Biopharmaceutics 81:3, pages 514-523.
Crossref
Crossref
Ju Young Lee, Da Yeon Kim, Gyeong Hae Kim, Kkot Nim Kang, Byoung Hyun Min, Bong Lee, Jae Ho Kim & Moon Suk Kim. (2011) Enhanced stability of nano-emulsified paclitaxel. Journal of Biomedical Science and Engineering 04:05, pages 352-356.
Crossref
Crossref
Laura Breen, Lisa Murphy, Joanne Keenan & Martin Clynes. (2008) Development of taxane resistance in a panel of human lung cancer cell lines. Toxicology in Vitro 22:5, pages 1234-1241.
Crossref
Crossref
Zyting Chu, Jen-Shi Chen, Chi-Ting Liau, Hung-Ming Wang, Yung-Chang Lin, Muh-Hwa Yang, Po-Min Chen, Erin R. Gardner, William D. Figg & Alex Sparreboom. (2008) Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients. Anti-Cancer Drugs 19:3, pages 275-281.
Crossref
Crossref
Janos Szebeni. (2005) Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology 216:2-3, pages 106-121.
Crossref
Crossref